[Cost-effectiveness of prophylaxis and treatment of influenza].
Rychlik
R
R
Institut für Empirische Gesundheitsökonomie, Burscheid. info@ifeg.de
Heinen-Kammerer
T
T
Rusche
H
H
Piercy
J
J
Scuffham
P
P
Zöllner
Y
Y
D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics*; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs; D006801:Humans; D007252:Influenza Vaccines / Q000191:economics*; D007251:Influenza, Human / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D018803:Models, Economic; D012307:Risk Factors; D014611:Vaccination / Q000191:economics*
D000998:Antiviral Agents; D007252:Influenza Vaccines